Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine

This study has been terminated.
(No patients enrolled. Delay due to optimisation of drug product formulation.)
Sponsor:
Information provided by:
BTG International Inc.
ClinicalTrials.gov Identifier:
NCT00888680
First received: April 27, 2009
Last updated: July 12, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given